North America Infectious Disease Diagnostics Market (2025-2030)
The North America Infectious Disease Diagnostics Market was valued at $889.5 Million in 2025 and projected to reach to $1435.9 Million by 2030, representing a compound annual growth rate of 10.0%. North America's infectious disease diagnostics market is positioned for sustained growth, supported by aging populations, increasing prevalence of infectious diseases, and robust healthcare spending.
North America Infectious Disease Diagnostics Market Trends and Insights
- This 10.0% compound annual growth rate reflects Latin America's increasing investment in healthcare infrastructure and diagnostic capabilities to combat endemic and emerging infectious diseases.
- Latin America's market growth is driven by rising disease prevalence, improved access to diagnostic technologies, and strengthened public health initiatives across the region. The infectious disease diagnostics sector in Latin America is benefiting from enhanced laboratory networks and point-of-care testing adoption.
- Latin America's healthcare systems are prioritizing rapid diagnostic solutions to address dengue, tuberculosis, COVID-19, and other infectious threats.
- Between 2025 and 2030, Latin America is expected to see significant expansion in molecular diagnostics, immunoassays, and culture-based testing platforms.
- Latin America's market trajectory reflects both regional demand and international partnerships strengthening diagnostic capacity throughout the region..
Key Market Statistics
- CAGR (2025-2030) 10.0% CAGR
- Market Size, 2025 ~USD 889.5 Million
- Forecast, 2030 ~USD 1435.9 Million
- Geography North America
North America Infectious Disease Diagnostics Market Overview
Market Leadership :
North America commands the largest share of the global infectious disease diagnostics market, driven by advanced healthcare infrastructure, high diagnostic adoption rates, and significant R&D investments across the US and Canada.
Rapid Technological Integration :
The region is experiencing accelerated adoption of molecular diagnostics, point-of-care testing, and AI-powered diagnostic platforms, enhancing disease detection speed and accuracy across clinical and non-clinical settings.
Strong Regulatory Framework :
FDA approvals and Health Canada regulations ensure high-quality diagnostic products, fostering innovation while maintaining stringent safety standards that support market credibility and consumer confidence.
Post-Pandemic Momentum :
Sustained investment in pandemic preparedness, surveillance systems, and diagnostic capacity building continues to drive market expansion beyond COVID-19, addressing emerging infectious disease threats.
North America Infectious Disease Diagnostics Market Dynamics
- The region's emphasis on preventive care and early disease detection drives demand for advanced diagnostic solutions.
- Strategic partnerships between diagnostic manufacturers and healthcare providers are expanding market reach and accessibility.
- Continued innovation in multiplex testing and rapid diagnostics will further accelerate adoption across hospitals, laboratories, and point-of-care settings throughout the forecast period..
Related Ecosystem
In Vitro Diagnostics
Medical Devices
Key Takeaways
- Latin America's infectious disease diagnostics market will grow from USD 889.5M (2025) to USD 1,435.9M (2030) at a 10.0% CAGR.
- Latin America is expanding point-of-care testing and molecular diagnostic capabilities to address endemic diseases and emerging pathogens.
- Latin America's healthcare infrastructure investments and public health initiatives are accelerating diagnostic adoption across the region.
- Latin America's market growth is supported by rising infectious disease prevalence and strengthened laboratory networks.
Infectious Disease Diagnostics Market Report Scope
| Report Metric | Details |
|---|---|
| Base Year | 2025 |
| Fastest Growing Segment | MOSQUITO-BORNE DISEASES (Disease Type) |
| Forecast Period | 2025–2030 |
| Growth Rate | CAGR of 9.7% from 2025 to 2030 |
| Largest Segment | LABORATORY TESTING (Type Of Testing) |
| Market Size Base Year (Billions) | ~USD 26.56 (2025) |
| Revenue Forecast (Billions) | ~USD 42.2 (2030) |
| Segments Covered | Product & Service, Type Of Testing, Sample Type, Disease Type, Type, Technology |
North America Infectious Disease Diagnostics Market Report Segmentation
6 segment dimensions are covered across the global market.
By Product & Service
- Instruments
- Reagents, Kits, And Consumables
- Software & Services
By Type Of Testing
- Laboratory Testing
- Poc Testing
By Sample Type
- Blood, Serum, And Plasma
- Other Sample Types
- Urine
By Disease Type
- Chlamydia Trachomatis
- Hepatitis
- Hiv
- Hospital-Acquired Infections
- Hpv
- Influenza
- Mosquito-Borne Diseases
- Neisseria Gonorrhea
- Other Infectious Diseases
- Syphilis
- Tuberculosis
By Type
- Hepatitis B
- Hepatitis C
- Other Hepatitis Diseases
By Technology
- Clinical Microbiology
- Dna Microarray
- Dna Sequencing & Next-Generation Sequencing
- Immunodiagnostics
- Isothermal Nucleic Acid Amplification Technology
- Other Technologies
- Polymerase Chain Reaction
Target Audience
- Diagnostic Manufacturers : Develop market entry strategies and product portfolios tailored to North America's advanced healthcare infrastructure and regulatory requirements for infectious disease testing.
- Healthcare Providers & Laboratories : Evaluate diagnostic solutions and procurement strategies to enhance testing capabilities, improve patient outcomes, and optimize operational efficiency across North American facilities.
- Investment & Private Equity Firms : Identify high-growth acquisition targets and investment opportunities in North America's infectious disease diagnostics sector with detailed market sizing and growth projections.
- Government & Public Health Agencies : Inform policy decisions, funding allocations, and pandemic preparedness strategies based on comprehensive market analysis and diagnostic capacity assessments across North America.
- Consultants & Business Strategists : Support client advisory services with evidence-based market intelligence, competitive benchmarking, and strategic recommendations for North American healthcare stakeholders.
Key Companies in the North America Infectious Disease Diagnostics Market
| Company | HQ | Ownership | Strongest segments |
|---|
Countries within North America - compare and drill down
| Country | 2025 size (native) |
|---|---|
| US | USD 8282.9 Million |
| Canada | USD 1773.5 Million |
Country market size visualization
Reasons to Buy this Report
- Market Size & Growth Data : Access comprehensive market valuation for North America's infectious disease diagnostics sector with country-level breakdowns for the US and Canada, enabling precise investment and expansion decisions.
- Competitive Landscape Intelligence : Understand market dynamics, key players, and competitive positioning specific to North America's regulatory environment and healthcare delivery systems.
- Technology Trend Analysis : Identify emerging diagnostic technologies gaining traction in North America, including molecular, immunological, and AI-integrated solutions driving market transformation.
- Strategic Market Segmentation : Leverage detailed segmentation by test type, end-user, and disease category to identify high-growth opportunities and target customer segments in North America.
- Regulatory & Reimbursement Insights : Navigate FDA approval pathways, insurance coverage trends, and reimbursement policies shaping market access and profitability in the US and Canadian markets.
Frequently asked questions
What is the market size of infectious disease diagnostics in Latin America?
Latin America's infectious disease diagnostics market is valued at USD 889.5 million in 2025 and is forecast to reach USD 1,435.9 million by 2030.
What is the growth rate for infectious disease diagnostics in Latin America?
Latin America's infectious disease diagnostics market is projected to grow at a compound annual growth rate (CAGR) of 10.0% from 2025 to 2030.
What diagnostic technologies are driving growth in Latin America?
Latin America's market growth is driven by molecular diagnostics, immunoassays, point-of-care testing platforms, and culture-based testing solutions addressing regional disease burdens.
Which infectious diseases are the primary focus in Latin America's diagnostics market?
Latin America's diagnostics market prioritizes dengue, tuberculosis, COVID-19, and other endemic and emerging infectious diseases prevalent across the region.
What factors are accelerating diagnostic adoption in Latin America?
Latin America's diagnostic adoption is accelerated by healthcare infrastructure investments, public health initiatives, laboratory network expansion, and increased disease prevalence awareness.
RESEARCH METHODOLOGY
The study analyzes key market dynamics, such as drivers, opportunities, restraints, challenges, and key player strategies. The objectives include tracking company developments such as acquisitions, product/service launches & approvals, expansions, agreements, and partnerships of the leading players. These parameters were evaluated on various parameters within the broad business & product strategy categories. Top-down and bottom-up approaches were used to estimate the market size. The market breakdown and data triangulation were used to estimate the market size of segments and subsegments.
The four steps involved in estimating the market size are:
Secondary Research
In the secondary research process, various secondary sources such as annual reports, press releases & investor presentations of companies, white papers, certified publications, articles by recognized authors, gold-standard & silver-standard websites, regulatory bodies, and databases (such as D&B Hoovers, Bloomberg Business, and Factiva) were referred to identify & collect information for this study.
Primary Research
In the primary research process, various sources from both the supply & demand sides were interviewed to obtain qualitative & quantitative information for this report. Primary sources included experts from the core & related industries and preferred suppliers, manufacturers, distributors, service providers, technology developers, researchers, and organizations related to all segments of this industry’s value chain. In-depth interviews were conducted with various primary respondents, including key industry participants, subject-matter experts, C-level executives of key market players, and industry consultants, to obtain & verify critical qualitative & quantitative information and assess prospects.
The following is a breakdown of the primary respondents:
Note 1: Others include sales, marketing, and product managers.
Note 2: Companies are classified into tiers based on their total revenues. As of 2024, Tier 1 = >USD 100 million, Tier 2 = USD 10 million to USD 100 million, and Tier 3 = < USD 10 million.
To know about the assumptions considered for the study, download the pdf brochure
| COMPANY NAME | DESIGNATION |
|---|---|
| Abbott (US) | Sales Manager |
| Becton, Dickinson and Company (US) | Product Manager |
Market Size Estimation
Both top-down and bottom-up approaches were used to estimate & validate the infectious disease diagnostics market's total size. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
- The key players in the industry have been identified through extensive secondary research
- The revenues generated by leading players operating in the infectious disease diagnostics market have been determined through primary & secondary research.
- All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources.
The research methodology used to estimate the market size includes the following:
Data Triangulation
After arriving at the overall market size by applying the abovementioned process, the total market was split into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.
Market Definition
Infectious disease diagnostics can be defined as various techniques and products (including kits, assays, tests, reagents, and analyzers) used by healthcare professionals to detect and diagnose disease-causing pathogens in human samples such as serum, blood, urine, throat swabs, and stool, among others.
Stakeholders
- Manufacturers & distributors of infectious disease diagnostics
- IVD companies
- Hospitals & clinics
- Academic research institutes
- Diagnostic laboratories
- Blood banks
- Home health agencies
- Market research & consulting firms
- Government associations
- Venture capitalists & investors
Report Objectives
- To define, describe, segment, and forecast the global infectious disease diagnostics market by product & service, type of testing, sample type, disease type, technology, clinical application, end user, and region
- To provide detailed information regarding the major factors influencing market growth (such as drivers, restraints, opportunities, and challenges)
- To analyze the micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall infectious disease diagnostics market
- To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
- To forecast the size of the market segments with respect to five regions, namely, North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa
- To profile the key players and comprehensively analyze their product portfolios, market positions, and core competencies
- To track and analyze company developments such as product launches & approvals, partnerships, acquisitions, agreements, and other developments
- To benchmark players within the infectious disease diagnostics market using the Company Evaluation Matrix framework, which analyzes market players on various parameters within the broad categories of business strategy, market share, and product offerings
Get the Full Infectious Disease Diagnostics Market Report
Full forecast, segment splits, and company analysis for all Infectious Disease Diagnostics Market.
- US Infectious Disease Diagnostics Market
- Canada Infectious Disease Diagnostics Market
- Germany Infectious Disease Diagnostics Market
- UK Infectious Disease Diagnostics Market
- France Infectious Disease Diagnostics Market
- Italy Infectious Disease Diagnostics Market
- Spain Infectious Disease Diagnostics Market
- China Infectious Disease Diagnostics Market
- Japan Infectious Disease Diagnostics Market
- India Infectious Disease Diagnostics Market
- Brazil Infectious Disease Diagnostics Market
- Mexico Infectious Disease Diagnostics Market
- United Arab Emirates Infectious Disease Diagnostics Market
- Rest Of Europe Infectious Disease Diagnostics Market
- Rest Of Asia Pacific Infectious Disease Diagnostics Market
Need a Tailored Report?
Customize this report to your needs
Get 10% FREE Customization
Customize This Report